SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. (KOSDAQ:A246960) from Lee, Moon Soo for KRW 21.8 billion on November 18, 2022. The offer per share is KRW 17,500. Transaction is expected to be closed on December 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,960 KRW | +2.17% | +3.94% | +1.01% |
1st Jan change | Capi. | |
---|---|---|
+1.01% | 47.8M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-12.32% | 33.03B | |
+54.44% | 24.68B | |
-17.39% | 15.12B | |
-9.14% | 12.81B | |
-10.48% | 11.79B | |
-42.45% | 11.64B | |
+7.27% | 8.9B |
- Stock Market
- Equities
- A246960 Stock
- News SCL Science Inc.
- SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.